Published in Immunol Cell Biol on June 01, 1999
C-terminal-binding protein corepresses epithelial and proapoptotic gene expression programs. Proc Natl Acad Sci U S A (2003) 2.25
Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res (2010) 1.89
Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure. Proc Natl Acad Sci U S A (2006) 1.73
Bi-compartmental communication contributes to the opposite proliferative behavior of Notch1-deficient hair follicle and epidermal keratinocytes. Development (2007) 1.46
Growth factors protect intestinal stem cells from radiation-induced apoptosis by suppressing PUMA through the PI3K/AKT/p53 axis. Oncogene (2009) 1.43
PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer. J Cancer Res Clin Oncol (2011) 1.21
Signalling pathways involved in antiproliferative effects of IGFBP-3: a review. Mol Pathol (2001) 1.21
Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis. Am J Pathol (2001) 1.05
Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3. Mol Cell Biol (2000) 1.00
Signaling mechanisms involved in the response to genotoxic stress and regulating lifespan. Int J Biochem Cell Biol (2007) 0.97
IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms. Cancer Biol Ther (2007) 0.97
Insulin-like growth factor binding protein 5 enhances survival of LX2 human hepatic stellate cells. Fibrogenesis Tissue Repair (2010) 0.92
Maintenance of naïve CD8 T cells in nonagenarians by leptin, IGFBP3 and T3. Mech Ageing Dev (2009) 0.92
The immune profile associated with acute allergic asthma accelerates clearance of influenza virus. Immunol Cell Biol (2014) 0.88
Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells. Am J Pathol (2002) 0.86
Pathobiology and chemoprevention of bladder cancer. J Oncol (2011) 0.84
Systemic administration of IGF-I enhances healing in collagenous extracellular matrices: evaluation of loaded and unloaded ligaments. BMC Physiol (2007) 0.83
Rapamycin inhibits growth factor-induced cell cycle regulation in pancreatic beta cells. J Investig Med (2008) 0.82
Skeletal muscle molecular alterations precede whole-muscle dysfunction in NYHA Class II heart failure patients. Clin Interv Aging (2012) 0.80
IGF-II transgenic mice display increased aberrant colon crypt multiplicity and tumor volume after 1,2-dimethylhydrazine treatment. J Carcinog (2006) 0.79
Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer. Curr Oncol (2013) 0.79
Effects of quercetin on insulin-like growth factors (IGFs) and their binding protein-3 (IGFBP-3) secretion and induction of apoptosis in human prostate cancer cells. J Carcinog (2006) 0.79
GPER1-mediated IGFBP-1 induction modulates IGF-1-dependent signaling in tamoxifen-treated breast cancer cells. Mol Cell Endocrinol (2015) 0.76
Bifidobacterial recombinant thymidine kinase-ganciclovir gene therapy system induces FasL and TNFR2 mediated antitumor apoptosis in solid tumors. BMC Cancer (2016) 0.75
IGFBP-3 may trigger osteoarthritis by inducing apoptosis of chondrocytes through Nur77 translocation. Int J Clin Exp Pathol (2015) 0.75
Suppression of IGF binding protein-3 by palmitate promotes hepatic inflammatory responses. FASEB J (2016) 0.75
Diagnosis of growth-hormone deficiency in adults. Lancet (1994) 5.93
Paracrine stimulation of human renal fibroblasts by proximal tubule cells. Kidney Int (1998) 2.11
Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J Biol Chem (1998) 1.59
Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun (1988) 1.58
Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin beta subunit. J Biol Chem (2000) 1.54
Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells. J Biol Chem (2000) 1.51
Long-term effects of insulin-like growth factor (IGF)-I on serum IGF-I, IGF-binding protein-3 and acid labile subunit in Laron syndrome patients with normal growth hormone binding protein. Eur J Endocrinol (1997) 1.42
Insulin-like growth factor-binding protein from human plasma. Purification and characterization. J Biol Chem (1986) 1.31
Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor. J Biol Chem (2000) 1.30
Amantadine dosage in treatment of Parkinson's disease. Lancet (1970) 1.30
Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma. J Clin Invest (1986) 1.28
Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab (1999) 1.24
Somatogenic receptors of rat liver: regulation by insulin. Endocrinology (1980) 1.23
Radioimmunoassay for somatomedin C: comparison with radioreceptor assay in patients with growth-hormone disorders, hypothyroidism, and renal failure. Clin Chem (1982) 1.22
Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia. Clin Endocrinol (Oxf) (1997) 1.19
Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. Mol Endocrinol (1988) 1.17
Insulin-like growth factor-binding protein-1 modulates blood glucose levels. Endocrinology (1991) 1.13
Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex. Endocrinology (1994) 1.12
IGFBP-3 binds GRP78, stimulates autophagy and promotes the survival of breast cancer cells exposed to adverse microenvironments. Oncogene (2012) 1.07
Treatment of Parkinson's disease with amantadine and levodopa. A one-year study. Lancet (1971) 1.06
Binding proteins for insulin-like growth factors in adult rat serum. Comparison with other human and rat binding proteins. Biochem Biophys Res Commun (1987) 1.05
A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness. J Clin Endocrinol Metab (2000) 1.04
Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit. J Biol Chem (1998) 1.03
Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3. J Biol Chem (1998) 1.02
Binding characteristics of pro-insulin-like growth factor-II from cancer patients: binary and ternary complex formation with IGF binding proteins-1 to -6. J Endocrinol (2000) 1.02
Two immunoreactive binding proteins for insulin-like growth factors in human amniotic fluid: relationship to fetal maturity. J Clin Endocrinol Metab (1987) 1.01
Insulin-like growth factor binding protein 3 accumulates to high levels in culture medium of senescent and quiescent human fibroblasts. Proc Natl Acad Sci U S A (1991) 1.01
Characterisation of recombinant glycosylation variants of insulin-like growth factor binding protein-3. J Endocrinol (1999) 1.01
The somatomedins: insulin-like growth factors. Adv Clin Chem (1986) 1.00
Monoclonal antibody against human somatomedin-C/insulin-like growth factor-I. J Clin Endocrinol Metab (1982) 1.00
Role of oleate in the regulation of "neutral" rabbit liver fructose 1,6-diphosphatase activity. J Biol Chem (1973) 0.99
Phosphorylation of insulin-like growth factor binding proteins. Mol Cell Endocrinol (1997) 0.99
Oncogenic ras causes resistance to the growth inhibitor insulin-like growth factor binding protein-3 (IGFBP-3) in breast cancer cells. J Biol Chem (1999) 0.99
Production of insulin-like growth factor I and its binding protein by adult rat hepatocytes in primary culture. Endocrinology (1985) 0.98
Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. J Clin Endocrinol Metab (2001) 0.98
Purification of tracer for somatomedin C radioimmunoassay by hydrophobic interaction chromatography. Clin Chem (1982) 0.97
Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis. Br J Cancer (2010) 0.97
Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. J Clin Invest (1993) 0.97
C-peptide secretion and insulin antibodies as determinants of stability in diabetes mellitus. Metabolism (1978) 0.96
Metabolic regulation of the growth hormone independent insulin-like growth factor binding protein in human plasma. Acta Endocrinol (Copenh) (1988) 0.96
Structural differences between insulin and somatomedin-C/insulin-like growth factor-1 receptors revealed by autoantibodies to the insulin receptor. Biochem Biophys Res Commun (1982) 0.96
The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group. J Clin Endocrinol Metab (2000) 0.96
Serum insulin-like growth factor I levels in adult diabetic patients: the effect of age. J Clin Endocrinol Metab (1986) 0.96
Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. J Clin Endocrinol Metab (1998) 0.95
Participation in an outreach-based coupon distribution program for free methadone detoxification. Hosp Community Psychiatry (1993) 0.95
Rat hepatocyte insulin-like growth factor I and binding protein: effect of growth hormone in vitro and in vivo. Endocrinology (1985) 0.95
Growth hormone-dependent insulin-like growth factor (IGF) binding protein from human plasma differs from other human IGF binding proteins. Biochem Biophys Res Commun (1986) 0.94
Regulation of hepatic growth hormone receptors by insulin. Biochem Biophys Res Commun (1978) 0.94
Accumulation of insulin-like growth factor binding protein-3 in conditioned medium of human fibroblasts increases with chronologic age of donor and senescence in vitro. J Cell Physiol (1993) 0.94
Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex. J Clin Endocrinol Metab (2000) 0.94
Insulin-like growth factor-binding protein 5 complexes with the acid-labile subunit. Role of the carboxyl-terminal domain. J Biol Chem (1998) 0.93
Immunoreactive somatomedin-C/insulin-like growth factor I and its binding protein in human milk. J Clin Endocrinol Metab (1984) 0.93
Comparative binding of bovine, human and rat insulin-like growth factors to membrane receptors and to antibodies against human insulin-like growth factor-1. Biochem J (1986) 0.92
Decreased insulin-like growth factor-II/mannose 6-phosphate receptor expression enhances tumorigenicity in JEG-3 cells. Cancer Res (1999) 0.92
Development of resistance to insulin-like growth factor binding protein-3 in transfected T47D breast cancer cells. Biochem Biophys Res Commun (1998) 0.91
Simplified approach to confidence limited in radioimmunassay. Clin Chem (1980) 0.91
Circulating levels of IGFs and IGF binding proteins in human cord serum: relationships to intrauterine growth. Regul Pept (1993) 0.91
Structure and functional expression of the acid-labile subunit of the insulin-like growth factor-binding protein complex. Mol Endocrinol (1992) 0.91
Transforming growth factor-beta stimulates production of insulin-like growth factor-binding protein-3 by human skin fibroblasts. Endocrinology (1991) 0.90
Changes in the circulating IGF system during short-term fasting and refeeding in rats. Am J Physiol (1999) 0.90
The role of the M6P/IGF-II receptor in cancer: tumor suppression or garbage disposal? Horm Metab Res (2004) 0.89
Complex formation by human insulin-like growth factor-binding protein-3 and human acid-labile subunit in growth hormone-deficient rats. Endocrinology (1994) 0.88
IGFBP-3 and apoptosis--a license to kill? Apoptosis (2001) 0.88
Interactions of oxygen at high pressure and radiation in Drosophila. J Gen Physiol (1966) 0.88
Measurement of insulin-like growth factor-II by radioreceptor assay using ovine placental membranes. Clin Endocrinol (Oxf) (1986) 0.88
Hormonal regulation of the peripubertal surge of insulin-like growth factor-I in the rat. Endocrinology (1987) 0.87
Glycosylation defects alter insulin but not insulin-like growth factor I binding to Chinese hamster ovary cells. J Biol Chem (1986) 0.87
Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes. J Clin Endocrinol Metab (1991) 0.87
Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol. Endocrinology (1995) 0.87
Regulation in vivo of the acid-labile subunit of the rat serum insulin-like growth factor-binding protein complex. Endocrinology (1994) 0.87
Stimulation of the neutral activity of rabbit liver fructose 1,6-diphosphatase by fatty acids. J Biol Chem (1972) 0.86
Insulin-like growth factor-binding proteins (IGF-BPs) produced by human skin fibroblasts: immunological relationship to other human IGF-BPs. Endocrinology (1988) 0.86
The acid-labile subunit of the serum insulin-like growth factor-binding protein complexes. Structural determination by molecular modeling and electron microscopy. J Biol Chem (1999) 0.86
Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion. J Clin Endocrinol Metab (1999) 0.86
Evidence that human bone cells in culture secrete insulin-like growth factor (IGF)-II and IGF binding protein-3 but not acid-labile subunit both under basal and regulated conditions. J Bone Miner Res (1995) 0.86
The effect of phosphorylation by casein kinase 2 on the activity of insulin-like growth factor-binding protein-3. Endocrinology (2000) 0.86
The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test. J Clin Endocrinol Metab (2003) 0.85
Production of insulin-like growth factor I and its binding protein in rat hepatocytes cultured from diabetic and insulin-treated diabetic rats. Endocrinology (1986) 0.85
Antibody against acid-stable insulin-like growth factor binding protein detects 150,000 mol wt growth hormone-dependent complex in human plasma. J Clin Endocrinol Metab (1985) 0.85
Secretion of soluble insulin-like growth factor-II/mannose 6-phosphate receptor by rat tissues in culture. Endocrinology (1991) 0.84
Mutagenesis of basic amino acids in the carboxyl-terminal region of insulin-like growth factor binding protein-5 affects acid-labile subunit binding. Endocrinology (2001) 0.84
Rat growth hormone (GH) but not prolactin (PRL) induces both GH and PRL receptors in female rat liver. Endocrinology (1984) 0.84
Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans. J Clin Endocrinol Metab (1999) 0.84
Serum "big insulin-like growth factor II" from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing. Proc Natl Acad Sci U S A (1993) 0.84
Identification of insulin-like growth factor-I and its receptors in the rat testis. Acta Endocrinol (Copenh) (1985) 0.84
Effect of hypophysectomy with and without thyroxine replacement on growth and circulating concentrations of insulin-like growth factors I and II in the fetal lamb. Endocrinology (1987) 0.83
Measurement of growth hormone and prolactin receptor turnover in rat liver. Endocrinology (1985) 0.83
Human renal fibroblasts modulate proximal tubule cell growth and transport via the IGF-I axis. Kidney Int (1997) 0.83
Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia. Clin Endocrinol (Oxf) (1997) 0.83
Insulin-like growth factor-binding protein-3 is functionally normal in pregnancy serum. J Clin Endocrinol Metab (1992) 0.83
Regulation of soluble insulin-like growth factor II/mannose 6-phosphate receptor in human serum: measurement by enzyme-linked immunosorbent assay. J Clin Endocrinol Metab (1999) 0.83
Relationship of somatomedin-C/insulin-like growth factor I levels to conventional nutritional indices in critically ill patients. Crit Care Med (1987) 0.83
Purification and immunological characterization of the rat liver insulin-like growth factor-II receptor. Endocrinology (1987) 0.82